Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127524071 | 12752407 | 1 | I | 20160617 | 20160914 | 20160915 | 20160915 | EXP | GB-MHRA-EYC 00144992 | GB-ROCHE-1830227 | ROCHE | 79.00 | YR | M | Y | 104.32000 | KG | 20160916 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127524071 | 12752407 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 7.14285714 | MG | Y | U | 125276 | 50 | MG | SOLUTION FOR INFUSION | /wk | |||
127524071 | 12752407 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 4 | C | BENDROFLUMETHIAZID | 2 | Unknown | 0 | ||||||||||||
127524071 | 12752407 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 6 | C | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 7 | C | DABIGATRAN | DABIGATRAN | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 8 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 9 | C | EPLERENONE. | EPLERENONE | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 10 | C | IRON SULPHATE | FERROUS SULFATE ANHYDROUS | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 11 | C | ISOCARBOXAZID | ISOCARBOXAZID | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
127524071 | 12752407 | 14 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 15 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | |||||||||||
127524071 | 12752407 | 16 | C | QUININE SULPHATE | QUININE SULFATE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127524071 | 12752407 | 1 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127524071 | 12752407 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127524071 | 12752407 | Arthritis | |
127524071 | 12752407 | Haemoptysis | |
127524071 | 12752407 | Pruritus | |
127524071 | 12752407 | Rash macular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127524071 | 12752407 | 1 | 20160617 | 20160722 | 0 |